These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33429466)

  • 1. The impact of the sample time of secondary bacterial culture on the risk of exposure to contaminated platelet components: A mathematical analysis.
    Moore RA; Schmidt RL; Metcalf RA
    Transfusion; 2021 Mar; 61(3):873-882. PubMed ID: 33429466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparative safety of bacterial risk control strategies for platelet components: a simulation study.
    Walker BS; Schmidt RL; Fisher MA; White SK; Blaylock RC; Metcalf RA
    Transfusion; 2020 Aug; 60(8):1723-1731. PubMed ID: 32632927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The negative secondary test for bacterial contamination: reducing the risk of septic transfusion reactions from platelets.
    Tomasulo PA; Jacobs MR
    Transfusion; 2017 Aug; 57(8):2054-2055. PubMed ID: 28656692
    [No Abstract]   [Full Text] [Related]  

  • 4. Financial analysis of large-volume delayed sampling to reduce bacterial contamination of platelets.
    Kacker S; Katz LM; Ness PM; Bloch EM; Goel R; Gehrie EA; Lokhandwala PM; Tobian AAR
    Transfusion; 2020 May; 60(5):997-1002. PubMed ID: 32275069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial contamination and septic transfusion reaction rates associated with platelet components before and after introduction of primary culture: experience at a US Academic Medical Center 1991 through 2017.
    Kundrapu S; Srivastava S; Good CE; Lazarus HM; Maitta RW; Jacobs MR
    Transfusion; 2020 May; 60(5):974-985. PubMed ID: 32357261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary bacterial culture of platelets to mitigate transfusion-associated sepsis: A 3-year analysis at a large academic institution.
    Fenwick AJ; Gehrie EA; Marshall CE; Tobian AAR; Shrestha R; Kacker S; Brunker PAR; Shifflett L; Carroll KC; Gozelanczyk D; Goel R; Ness PM; Bloch EM
    Transfusion; 2020 Sep; 60(9):2021-2028. PubMed ID: 32750171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual bacterial detection rates after primary culture as determined by secondary culture and rapid testing in platelet components: A systematic review and meta-analysis.
    Walker BS; White SK; Schmidt RL; Metcalf RA
    Transfusion; 2020 Sep; 60(9):2029-2037. PubMed ID: 32757411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial contamination rate of platelet components by primary culture: a systematic review and meta-analysis.
    White SK; Schmidt RL; Walker BS; Metcalf RA
    Transfusion; 2020 May; 60(5):986-996. PubMed ID: 32181889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of secondary bacterial culture testing of platelets to mitigate residual risk of septic transfusion reactions.
    Bloch EM; Marshall CE; Boyd JS; Shifflett L; Tobian AAR; Gehrie EA; Ness PM
    Transfusion; 2018 Jul; 58(7):1647-1653. PubMed ID: 29607515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets.
    Schrezenmeier H; Walther-Wenke G; Müller TH; Weinauer F; Younis A; Holland-Letz T; Geis G; Asmus J; Bauerfeind U; Burkhart J; Deitenbeck R; Förstemann E; Gebauer W; Höchsmann B; Karakassopoulos A; Liebscher UM; Sänger W; Schmidt M; Schunter F; Sireis W; Seifried E
    Transfusion; 2007 Apr; 47(4):644-52. PubMed ID: 17381623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incremental benefit of anaerobic culture for controlling bacterial risk in platelets: a systematic review and meta-analysis.
    Corean J; White SK; Schmidt RL; Walker BS; Fisher MA; Metcalf RA
    Vox Sang; 2021 Apr; 116(4):397-404. PubMed ID: 32996621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial contamination of platelet concentrates produced in New Zealand.
    Dickson M; Dinesh D
    N Z Med J; 2013 May; 126(1374):12-21. PubMed ID: 23799378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial contamination of platelet concentrates: where are we today?
    Goldman M
    Vox Sang; 2004 Jul; 87 Suppl 2():90-2. PubMed ID: 15209888
    [No Abstract]   [Full Text] [Related]  

  • 14. Quality Improvement After Multiple Fatal Transfusion-Transmitted Bacterial Infections.
    Corean J; Al-Tigar R; Pysher T; Blaylock R; Metcalf RA
    Am J Clin Pathol; 2018 Mar; 149(4):293-299. PubMed ID: 29462235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an automated microbiologic blood culture device for detection of bacteria in platelet components.
    Wagner SJ; Robinette D
    Transfusion; 1998 Jul; 38(7):674-9. PubMed ID: 9683107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion-related sepsis: a silent epidemic.
    Benjamin RJ
    Blood; 2016 Jan; 127(4):380-1. PubMed ID: 26823510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A national survey of hospital-based transfusion services on their approaches to platelet bacterial risk mitigation in response to the FDA final guidance for industry.
    Lu W; Delaney M; Dunbar NM; Rossmann SN; Fung M
    Transfusion; 2020 Aug; 60(8):1681-1687. PubMed ID: 32564352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial contamination of platelet components: potential solutions to prevent transfusion-related sepsis.
    Corash L
    Expert Rev Hematol; 2011 Oct; 4(5):509-25. PubMed ID: 21939419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between bacterial load, species virulence, and transfusion reaction with transfusion of bacterially contaminated platelets.
    Jacobs MR; Good CE; Lazarus HM; Yomtovian RA
    Clin Infect Dis; 2008 Apr; 46(8):1214-20. PubMed ID: 18444858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limitations of current practices in detection of bacterially contaminated blood products associated with suspected septic transfusion reactions.
    Martin IW; Cohn CS; Delaney M; Fontaine MJ; Shih AW; Dunbar NM;
    Transfusion; 2021 Aug; 61(8):2414-2420. PubMed ID: 34181247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.